Abstract
The current COVID-19 global pandemic caused by SARS-CoV-2 has claimed more than 6 million lives since its emergence in December 2019. The first oral coronavirus main protease inhibitor, nirmatrelvi...
Cite
CITATION STYLE
APA
Chia, C. S. B., & Inoue, M. (2022). Oral Nonpeptidic, Noncovalent Triazine Coronavirus Main Protease Inhibitors for Treating COVID-19. ACS Medicinal Chemistry Letters, 13(9), 1394–1396. https://doi.org/10.1021/acsmedchemlett.2c00349
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free